Twist Bioscience Corp Stock
Price
Target price
€25.90
€25.90
-1.070%
-0.28
-1.070%
€44.82
12:55 / Tradegate
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Twist Bioscience Corp Stock
A loss of -1.070% shows a downward development for Twist Bioscience Corp.
We see a rather positive sentiment for Twist Bioscience Corp with 11 Buy predictions and 2 Sell predictions.
With a target price of 44 € there is a hugely positive potential of 69.88% for Twist Bioscience Corp compared to the current price of 25.9 €.
So far the community has only identified positive things for Twist Bioscience Corp stock. The most positive votes were given for criterium "Revenue growth".
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
S********** s********
?
B****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | -1.070% | -9.693% | -1.282% | -32.299% | -42.751% | -19.816% | -66.000% |
| Pacira Pharmaceuticals | -0.520% | 4.420% | -9.135% | 26.846% | 2.162% | -61.111% | -59.091% |
| Rockwell Medical Inc. | 1.940% | -3.295% | -10.068% | -74.016% | -54.142% | -0.054% | -88.868% |
| Vericel Corp. | -0.640% | 0.637% | 16.176% | -22.167% | -42.018% | 18.396% | 74.924% |
Comments
Twist Bioscience (NASDAQ:TWST) had its price target lowered by analysts at Evercore ISI from $46.00 to $42.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat
The comment is under review
Twist Bioscience Co. (NASDAQ: TWST) had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $55.00 to $48.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat